Skip to main content
Log in

Fatty acid-binding protein 5 activates cyclooxygenase-2 and promotes hypoxic injury in LO2 cells

  • Original Article
  • Published:
Molecular & Cellular Toxicology Aims and scope Submit manuscript

Abstract

Background

Hepatic hypoxia always results in liver inflammation and dysfunction. Fatty acid-binding protein 5 (FABP5) has been reported as a hypoxia-inducible gene and a regulator of inflammatory reaction.

Objective

To evaluate the effects of FABP5 on hypoxic liver injury and its potential mechanisms.

Results

FABP5 was hypoxia-inducible expression in liver tissues and LO2 cells. The expression levels of IL6 and TNFα were upregulated with the increasing expression of FABP5 in LO2 cells. Downregulation of FABP5 expression decreased the expression levels of ALT, AST and increased cell viability of hypoxic LO2 cells. Downregulation of FABP5 expression inhibited the cyclooxygenase-2/prostaglandin E2 (COX-2/PGE2) pathway and decreased inflammatory reaction in hypoxic LO2 cells.

Conclusions

FABP5 was shown to activate COX-2/PGE2 pathway and promote hypoxic injury in LO2 cells. FABP5 may be a potential target for the treatment of hypoxic liver injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abe Y, Uchinami H, Kudoh K et al (2012) Liver epithelial cells proliferate under hypoxia and protect the liver from ischemic injury via expression of HIF-1 alpha target genes. Surgery 152:869–878

    Article  Google Scholar 

  • Armstrong EH, Goswami D, Griffin PR, Noy N, Ortlund EA (2014) Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor β/δ (FABP5-PPARβ/δ) signaling pathway. J Biol Chem 289(21):14941–14954

    Article  CAS  Google Scholar 

  • Bilzer M, Gerbes AL (2002) Pivotal role of G-protein–coupled adenosine A2a receptors in protection of the liver against inflammation and ischemia-reperfusion injury. Hepatology 36:1009–1011

    Article  Google Scholar 

  • Bogdan D, Falcone J, Kanjiya MP et al (2018) Fatty acid-binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation. J Biol Chem 293:5295–5306

    Article  CAS  Google Scholar 

  • Colville-Nash PR, Gilroy DW (2000) COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation? Prostaglandins Other Lipid Mediat 62:33–43

    Article  CAS  Google Scholar 

  • da Rosa DP, Forgiarini LF, Baronio D, Feijó CA, Martinez D, Marroni NP (2012) Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver. Med Inflam 2012:879419

    Google Scholar 

  • Davies NM, Mclachlan AJ, Day RO, Williams KM (2000) Clinical pharmacokinetics and pharmacodynamics of celecoxib. Clin Pharmacokinet 38:225–242

    Article  CAS  Google Scholar 

  • Echizen K, Hirose O, Maeda Y, Oshima M (2016) Inflammation in gastric cancer: interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways [published correction appears in Cancer Sci. 2016 Jul; 107(7):1059]. Cancer Sci 107:391–397

    Article  CAS  Google Scholar 

  • Farombi EO, Shrotriya S, Surh YJ (2009) Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-kappaB and AP-1. Life Sci 84:149–155

    Article  CAS  Google Scholar 

  • Han Q, Yeung SC, Ip MSM, Mak JCW (2010) Effects of intermittent hypoxia on A-/E-FABP expression in human aortic endothelial cells. Int J Cardiol 145:396–398

    Article  Google Scholar 

  • Haunerland NH, Spener F (2004) Fatty acid-binding proteins–insights from genetic manipulations. Prog Lipid Res 43(4):328–349

    Article  CAS  Google Scholar 

  • Hohoff C, Börchers T, Rüstow B, Spener F, van Tilbeurgh H (1999) Expression, purification, and crystal structure determination of recombinant human epidermal-type fatty acid binding protein. Biochemistry 38:12229–12239

    Article  CAS  Google Scholar 

  • Khan AA, Iadarola M, Yang HYT (2007) Dionne RA. Expression of COX-1 and COX-2 in a clinical model of acute inflammation. J Pain 8:349–354

    Article  CAS  Google Scholar 

  • Kreiss C, Birder LA, Kiss S, VanBibber MM, Bauer AJ (2003) COX-2 dependent inflammation increases spinal Fos expression during rodent postoperative ileus. Gut 52:527–534

    Article  CAS  Google Scholar 

  • Lee IT, Lin CC, Lin WN et al (2013) Lung inflammation caused by adenosine-5’-triphosphate is mediated via Ca2+/PKCs-dependent COX-2/PGE2 induction. Int J Biochem Cell Biol 45(8):1657–1668

    Article  CAS  Google Scholar 

  • Lefere S, Van Steenkiste C, Verhelst X, Van Vlierberghe H, Devisscher L, Geerts A (2016) Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease. Cell Mol Life Sci 73(18):3419–3431

    Article  CAS  Google Scholar 

  • Lin BR, Yu CJ, Chen WC et al (2009) Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling. J Biomed Sci 16:35

    Article  Google Scholar 

  • Moore SM, Holt VV, Malpass LR, Hines IN, Wheeler MD (2015) Fatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages. Mol Immunol 67:265–275

    Article  CAS  Google Scholar 

  • Ohata H, Kinaret P, Kilpeläinen M et al (2015) Level of fatty acid binding protein 5 (FABP5) is increased in sputum of allergic asthmatics and links to airway remodeling and inflammation. PLoS ONE 10:e0127003

    Article  Google Scholar 

  • Ohata T, Yokoo H, Kamiyama T et al (2017) Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition. Cancer Med 6(5):1049–1061

    Article  CAS  Google Scholar 

  • Rao D, Perraud AL, Schmitz C, Gally F (2017) Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter. PLoS ONE 12:e0178021

    Article  Google Scholar 

  • Rosmorduc O, Housset C (2010) Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin Liver Dis 30(3):258–270

    Article  CAS  Google Scholar 

  • Suematsu M, Suzuki H, Ishii H et al (1992) Topographic dissociation between mitochondrial dysfunction and cell death during low-flow hypoxia in perfused rat liver. Lab Invest 67:434–442

    CAS  PubMed  Google Scholar 

  • van der Graaff D, Kwanten WJ, Francque SM (2019) The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis. Med Hypotheses 122:188–197

    Article  Google Scholar 

  • Wei X, Tang C, Lu X et al (2015) MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma. Oncotarget 6:18389–18405

    Article  Google Scholar 

  • Xiong X, Ren Y, Cui Y, Li R, Wang C, Zhang Y (2017) Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation. Biomed Pharmacother 96:1292–1298

    Article  CAS  Google Scholar 

  • Yu X, Yang Y, Yuan H et al (2017) Inhibition of COX-2/PGE2 cascade ameliorates cisplatin-induced mesangial cell apoptosis. Am J Transl Res 9(3):1222–1229

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang Y, Li Q, Rao E et al (2015) Epidermal Fatty Acid binding protein promotes skin inflammation induced by high-fat diet. Immunity 42:953–964

    Article  CAS  Google Scholar 

  • Zhang P, Yu J, Gui Y, Sun C, Han W (2019) Inhibition of miRNA-222-3p relieves staphylococcal enterotoxin B-induced liver inflammatory injury by upregulating suppressors of cytokine signaling 1. Yonsei Med J 60:1093–1102

    Article  CAS  Google Scholar 

  • Zhuang Y, Zhao F, Liang J et al (2017) Activation of COX-2/mPGES-1/PGE2 cascade via NLRP3 inflammasome contributes to albumin-induced proximal tubule cell injury. Cell Physiol Biochem 42(2):797–807

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (No 81702408). The authors thank Pro Rui Liao (Department of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University) for some helpful advice in article revision.

Funding

This work was supported by the National Natural Science Foundation of China (No 81702408).

Author information

Authors and Affiliations

Authors

Contributions

LP: conceptualization, methodology, software, and writing—reviewing and editing YP: data curation and writing—original draft preparation. HX: visualization and investigation. XD: supervision, software, and validation. QC: investigation and software.

Corresponding author

Correspondence to Long Pan.

Ethics declarations

Conflict of interest

Long Pan declares that he has no conflict of interest. Yihan Pang declares that she has no conflict of interest. Heng Xiao declares that he has no conflict of interest. Xin Deng declares that he has no conflict of interest. Qingsong Chen declares that he has no conflict of interest.

Ethical approval

All the authors declare that all the experimental procedures were performed in accordance with the ethical standards as recommended by the Institutional Committee of Review Board of the First Affiliated Hospital of Chongqing Medical University.

Informed consent

Informed consent was obtained from each patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 52 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pan, L., Pang, Y., Xiao, H. et al. Fatty acid-binding protein 5 activates cyclooxygenase-2 and promotes hypoxic injury in LO2 cells. Mol. Cell. Toxicol. 18, 23–30 (2022). https://doi.org/10.1007/s13273-021-00158-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13273-021-00158-1

Keywords

Navigation